Jump to Main Content

ASH Annual Meeting and Exposition

Annual Meeting Sessions on Diversity, Equity, and Inclusion

As a global hematology community, ASH understands the importance of having individuals with diverse perspectives and experiences in all areas of the field and strives to improve the outcomes for individuals with hematologic diseases.  Diversity, Equity, and Inclusion Sessions examine the science of how identity differences impact outcomes and how attendees can mitigate those differences to achieve equitable outcomes for all individuals with hematologic diseases and disorders.

For more information on ASH's efforts in the DEI space, please visit the ASH's DEI page.


Education Program

A Little Less Conversation, a Little More Action: An Outcome Equity Roadmap for Children and AYAs With Leukemia and Lymphoma



Centuries of structural racism have contributed to discrimination, environmental and social injustice, and household material hardship among historically marginalized populations. Recent studies have highlighted the impact of factors such as income and insurance status on cancer outcomes and health equity. Under-representation of specific groups has limited our understanding of cancer risk, disease biology, treatment-related toxicities, and patient-reported outcomes. The educational objective of this session is to present the latest evidence regarding modifiable factors that contribute to outcome disparities in childhood/adolescent and young adult (AYA) hematologic malignancies, and to discuss potential targets for interventions that address these disparities. Dr. Ji will present an in-depth overview of public health insurance programs in the U.S. and related implications on outcome disparities among AYAs with blood cancers. Using a case-based approach, Dr. Ji will discuss opportunities to improve access to high-quality public health insurance, subsequent to the Affordable Care Act. Dr. Umaretiya will discuss the role of social determinants of health (SDOH) as modifiable drivers of outcome inequities in pediatric oncology. She will review the prevalence of SDOH in pediatric oncology, present historically marginalized parent perspectives on unmet social needs during cancer care, and highlight novel interventions addressing this population’s SDOH and social needs. Dr. Mittal will discuss factors contributing to low rates of enrollment of AYAs with hematologic malignancies to clinical trials, including a lack of availability and accessibility. She will provide an up-to-date review of collaborative initiatives that are addressing some of these barriers to improve AYA access to cancer clinical trials.

Chair:

Maria Monica Monica Gramatges , MD,PhD
Texas Children's Hospital
Houston,  TX

Speakers:

Xu Ji , PhD
Emory University School of Medicine
Atlanta,  GA
The Lasting Impact of the ACA: How Medicaid Expansion Reduces Outcome Disparities in AYAs With Leukemia and Lymphoma

Puja J. Umaretiya , MD
Childrens Medical Center Dallas, UT Southwestern
Dallas,  TX
Targeting Hardship: Poverty as a Modifiable Risk Factor in Childhood Leukemia and Lymphoma Treatment

Nupur Mittal Nupur Mittal , MD
Rush University Medical Center
Chicago,  IL
Sharing is Caring: A Network Collaborative Approach to Identify and Address Barriers in Accessing Clinical Trials in AYAs with Leukemia and Lymphoma

back to top

Hematologic Management of the Patient with Heavy Menstrual Bleeding



Heavy menstrual bleeding (HBM) has an important impact on the physical, emotional and social well-being, and in adolescents, can be the only clinical sign of an underlying bleeding disorder. Due to several medical, economic and social factors, it remains a significantly underdiagnosed and undertreated condition. Hematologists play an important role in the evaluation and care of patients with anemia from chronic blood loss, and may be the first clinicians to identify HMB as its cause.  This education session will describe a clinical multidisciplinary approach to the evaluation and treatment of patients presenting with HMB, with a special focus on adolescents. It will provide an overview of diagnostic and management strategies to broaden the tools available to hematologists caring for these patients in different clinical settings.

Dr. Allison P Wheeler will discuss the various tools available for the quantification of menstrual blood loss, including those that evaluate the effect of HMB on quality of life; followed by a description of non-surgical (hormonal and non-hormonal) treatments of HMB, their efficacy, contraindications and selection of the most appropriate therapy using shared decision-making.

Dr. Juliana Perez Botero will present a focused approach to laboratory testing (screening and confirmatory) for patients presenting with HMB in whom von Willebrand Disease is suspected, with emphasis on the effect of pre-analytical variables and testing methodology on the results and their clinical interpretation.

Dr. Janice Staber will discuss the value of multidisciplinary clinics specializing in the care of adolescents with HMB, including their critical components and different care delivery models, and share important lessons learned during the development and implementation of one of these clinics.

Chair:

Juliana Perez Botero , MD
Versiti
Milwaukee,  WI

Speakers:

Allison P Wheeler , MD
Washington Center for Bleeding Disorders
Seattle,  WA
Quantifying Menorrhagia and Overview of Non-Surgical Management of Heavy Menstrual Bleeding

Juliana Perez Botero , MD
Versiti
Milwaukee,  WI
Von Willebrand's Disease and Heavy Menstrual Bleeding: When to Test, How to Test, and Use of Targeted Therapies

Janice Staber , MD
University of Iowa Stead Family Children's Hospital
Iowa City,  IA
Heavy Menstrual Bleeding Clinics for Adolescents

back to top

Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?



Venous thromboembolism is a common disease, with an incidence of one to three per 1000 individuals per year. Numerous risk factors are known, which can be divided into genetic and acquired. One of the most well-known acquired risk factors is exposure to endogenous (i.e. pregnancy) and exogenous female hormones, including oral contraceptive use, hormone substitution therapy, and gender-affirming hormone therapy. Thrombosis specialists are frequently consulted about optimal hormonal therapy in individuals with an increased risk of venous thromboembolism, as well as optimal management of pregnancy-related venous thromboembolism.

Dr Leslie Skeith will cover contraceptive-related VTE risk by agent and by clinical scenario, including in patients with inherited thrombophilia, systemic lupus erythematosus with or without antiphospholipid antibodies or antiphospholipid syndrome, and sickle cell disease considering contraception. Relevant clinical practice guidelines are reviewed. A multidisciplinary approach to counselling is needed for patient-focused decision-making.

Dr Joseph Shatzel will explore the hematologic complications of gender-affirming therapy, with a particular focus on managing and mitigating the thrombotic risks linked to exogenous estrogen use. He will detail existing data on thrombotic risks reported in transgender individuals and provide insights from studies involving cisgender women and men who receive exogenous estrogen and testosterone, providing important contextual background. He will delve into strategies for addressing testosterone-induced erythrocytosis and iron deficiency in transgender individuals undergoing hormone therapy.

Dr Saskia Middeldorp will present clinical cases of VTE related to hormonal contraceptive use and pregnancy to illustrate key considerations for clinical practice. Practice points for primary VTE treatment and the evidence on the risk of recurrent VTE and bleeding in this population are detailed. The potential value of thrombophilia testing is described including the: “who, why, when, what and how”. We also discuss key aspects of shared decision making for anticoagulant duration, including a reduced dose anticoagulant strategy in hormone-related VTE.

Chair:

Saskia Middeldorp , MD, PhD
Radboud university medical center
Nijmegen,  Netherlands

Speakers:

Leslie Skeith
University of Calgary
Calgary,  AB, Canada
Estrogen, Progestin, and Beyond: Thrombotic Risk and Contraceptive Choices

Joseph J. Shatzel , MD
Oregon Health and Science University
Portland,  OR
Gender-Affirming Hormone Therapy in the Transgender Patient: Influence on Thrombotic Risk

Saskia Middeldorp , MD, PhD
Radboud university medical center
Nijmegen,  Netherlands
Hormone-Related Thrombosis: Duration of Anticoagulation, Risk of Recurrence, and the Role of Hypercoagulability Testing

back to top

The Expanding Landscape of Treatment for ITP



The management of Immune Thrombocytopenia (ITP) has seen a renaissance in the available therapies and in the approach to patients with the diagnosis in recent years. This has lead to an expanding number of therapeutic options for patients and physicians to consider as they embark on their therapeutic journey with ITP. Dr. Waleed Ghanima will discuss the new approaches incorporating combination strategies in management of patients with ITP including suggestions for when to consider moving beyond mono therapy for ITP. Dr. Annemarie Fogerty will then discuss updates on ITP in pregnancy, a special category of ITP with implications for both maternal and fetal health and provide the most information on both treatments and outcomes. Finally, Dr. Michele Lambert will then describe current clinical trials (or recently completed) and provide information on novel therapeutics that are in development as well as the current treatment gaps where additional study is needed.

Chair:

Michele P. Lambert , MD
Children's Hospital of Philadelphia
Philadelphia,  PA

Speakers:

Waleed Ghanima , MD, PhD
Østfold Hospital
Gralum,  Norway
Insights on Treatment of ITP: Algorithm for Management and Role of Multi-Modal Therapy

Annemarie E Fogerty , M.D.
Massachusetts General Hospital
Boston,  MA
Management of ITP during Pregnancy

Michele P. Lambert , MD
Children's Hospital of Philadelphia
Philadelphia,  PA
On the Horizon: Upcoming New Agents for the Management of ITP

back to top

General Sessions

2024 Ham-Wasserman Lecture



This lectureship was named in honor of two past Society presidents, the late Dr. Thomas Hale Ham and the late Dr. Louis R. Wasserman, distinguished American Hematologists that contributed extensively to the Society. The lectureship is offered to an individual from outside the United States who has made a major contribution to our understanding of an area that relates to hematology. This year's honoree, Dr. Dipty Jain will be honored for her pioneering work in the field of sickle cell disease. 
More information to come.

Chair:

Mohandas Narla , DSc
New York Blood Center Enterprises
New York,  NY

Speaker:

Dipty Lalit Jain , MD,MBBS
Indira Gandhi Government Medical College and Hospital
NAGPUR,  India
Sickle Cell Disease in Developing Countries

back to top

Health Equity Studio

Access to Care in Low Resource Settings



back to top

Best Practices for Serving Underserved Communities



back to top

Building Trust Between Providers and Patient Communities



back to top

Care of Undocumented Patients



back to top

Financial Toxicity



back to top

Patient-Centered Care and Shared Decision Making



back to top

Special-Interest Sessions

Health Equity Rounds Lunch



Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.

CoChair:

Speakers:

Ash Alpert
Yale School of Medicine
New Haven,  CT
Hematologic Aspects of Gender Affirming Care

Eric Scott Mullins , MD
Cincinnati Children's Hospital Medical Center
Cincinnati,  OH
Hematologic Aspects of Gender Affirming Care

back to top

Health Equity Symposium: Race, Structural Racism and the Social Determinants of Health in Hematology



The misuse of race in medicine has far-reaching implications across practice, teaching, and research in hematology. This session is intended to explore what race is and what it is not, and illustrate how systemic factors, including racism, influence health care access and outcomes. The session will also explore strategies to tackle systemic racism in patient care and how to create conditions for equitable care for patients with blood diseases. Dr. Joseph L. Graves Jr. will provide a summary of the history of biological conceptions of race and describe modern evolutionary conceptions of race. He will then address how this understanding can be useful in employing the power of modern genomic tools applied to human biological diversity, including how the use of these tools completely unravels the false premises of racial medicine. Dr. Chanita Hughes Halbert will define health care disparities and describe the nature and distribution of social determinants of disparities in disease risk and outcomes. She will also provide an overview of structural racism and its impact on health care outcomes in diverse populations.

Chair:

Deirdra R Terrell , PhD
University of Oklahoma Health Sciences Center
Oklahoma City,  OK

Speakers:

Joseph L Graves Jr. , PhD
North Carolina A&T State University
Greensboro,  NC
The Myth of Race in Medical Science

Chanita Hughes Halbert , PhD
University of Southern California
Los Angeles,  CA
Structural Racism, the Social Determinants of Health, and Healthcare Outcomes – Understanding Inequity and What to Do About It

back to top

LGBTQIA+ Community Networking Lunch (for in-person participants)



This is an informal community-building and networking event for members of the LGBTQIA+ community attending the meeting. The event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create a sense of belonging and allyship and, where possible, identify opportunities to learn more about the experiences and needs of the community to allow us to have a greater impact in our DEI efforts. back to top

Medical Educators Symposium



The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with an hour of general sessions focused on medical education principles and then followed by simultaneous breakout sessions that happen twice.

Chair:

Hetty E. Carraway , MD,MBA
Cleveland Clinic
Cleveland,  OH

Speakers:

Alison Loren , MD
University of Pennsylvania
Philadelphia,  PA
General Session 1: Paving a Career in Medical Education & Scholarship

Megan Dupuis
Vanderbilt University
Durham,  NC
General Session 2: Utilizing Humanities to Influence and Tailor Hematology Curriculum for Adult Learners

Layla Van Doren
Yale University
New York,  NY
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum

Alexander A Boucher , MD
University of Minnesota
Minneapolis,  MN
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum

Beverly Schaefer , MD
University of Buffalo
Buffalo,  NY
Breakout 1: Challenges for Course Development

Jason A Freed , MD
Beth Israel Deaconess
Boston,  MA
Breakout 3: Cutting-Edge Technology in Education Delivery

Thomas W. LeBlanc , MD, MA, MHS
Duke University Medical Center
Durham,  NC
Breakout 4: Developing a Palliative Care/Difficult Discussion Curriculum

back to top

Race and Ancestry in Precision Medicine



Race and ancestry, historically, have been poorly considered in basic and translational research design and clinical diagnoses. This session will describe how race and ancestry can inform hematology research conduct, specifically in clinical and genetic population profiling, interpretation of common hematologic tests, development of diagnostics, and overall precision medicine. The speakers selected in this session have incorporated race and ancestry in their own research and will be sharing their insights to help educate hematology investigators and clinicians understand how to consider race and ancestry into their own research and practice.

CoChair:

Speakers:

Keolu Fox
University of California, San Diego
San Diego,  CA
Incorporating Indigenous Perspectives into Population Genetics

Ann-Kathrin Eisfeld , MD
The Ohio State University
Columbus,  OH
Risk Re-Stratification Based on Black AML Patient Exome Data

Maureen Achebe
Brigham and Women's Hospital
Boston,  MA
How Inappropriate Reference Ranges Can Propagate Systemic Racism

back to top

Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities



This year's Quality Symposium will focus on practical strategies for combatting healthcare disparities. First, Dr. Melissa Creary will discuss the Michigan Social Health Interventions to Eliminate Disparities (MSHIELD) program, a statewide data-driven, community-partnered, and equity-centered quality improvement effort. Then Dr. Michelle Sholzberg will review the development and impact of the "Raise the Bar" project, which aims to eliminate disparities in the recognition and management of iron deficiency by adjusting reference ranges. The session will conclude with a talk by Dr. Thomas Greg Knight on mitigating the impact of financial toxicity in patients with hematologic malignancies.

CoChair:

Speakers:

Melissa Creary
University of Michigan School of Public Health
Ann Arbor,  MI
MSHIELD - Michigan Social Health Interventions to Eliminate Disparities

Michelle Sholzberg , MD
University of Toronto
Toronto,  ON, Canada
Raise the Bar - Combatting Disparities in the Recognition and Management of Iron Deficiency

Thomas G. Knight , MD
Atrium Health
Charlotte,  NC
Cancer and Poverty - Mitigating the Impact of Financial Toxicity in Patients with Hematologic Malignancies

back to top

Wake Up to DEI Community Networking Brunch (for in-person participants)



This is a community-building and networking event for members that fall within the diversity, equity, and inclusion (DEI) umbrella to gather and get to know each other across the varying and intersectional communities. The event will include remarks from a member of the ASH Committee on Diversity, Equity, and Inclusion.

The event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create space for ASH DEI communities and allies and, where possible, identify opportunities to learn more about the experiences and needs of these communities to allow ASH to have a greater impact in its DEI efforts. back to top

Women In Hematology Networking Event (for in-person participants)



This popular annual reception will provide a space where all can gather in an informal environment and connect with peers and potential mentors. The event will include a panel discussion focused on leadership through a gender and career development lens as well as ample networking opportunities.

Spotlight Sessions

Curative Therapies for Sickle Cell Disease: Option for Some but Not Quite All



Despite substantial improvements in care, individuals with sickle cell disease continue to experience substantial morbidity and a shortened life expectancy. With recent advances in the development of curative therapies, including allogeneic stem cell transplantation and gene therapy, it is important to identify barriers to accessing these treatments and adequately define suitable candidates for curative therapies.

In this session, Dr. Santosh Saraf will review the current guidelines for curative therapies, discuss the potential benefits and risks of the different curative therapies, and provide insight on when to refer patients for curative therapy.

In the second presentation, Dr. Payal Desai will discuss the various barriers to accessing curative therapies as well as the need for development of an integrated care approach.

Chair:

Kenneth I. Ataga , MD
University of Tennessee Health Sciences Center, Memphis
Memphis,  TN

Speakers:

Santosh L. Saraf , MD
University of Illinois Chicago
Chicago,  IL
Curative Therapies in Sickle Cell Disease: Which Patient, What Modality, and When to Refer

Payal Desai , MD
Wake Forest University
Charlotte,  NC
Systemic Barriers to Curative Therapy and Need for Integrated Care

back to top

Trainee Activities and Services

ASH Talk #2: International Medical Graduates



The ASH Talk sessions are 20-minute presentations, similar to a TED Talk, with dynamic speakers presenting timely topics. ASH Talks are the core plenary sessions of ASH-a-Palooza that take place at the top of each hour. The talks contain little to no slides and draw the entire audience of ASH-a-Palooza together, between the other microlearning and networking sessions that occur throughout the event (Blood Drops and Blood Buddies).

Chair:

Kaitlyn C Dykes , MD,BS
University of California San Diego
La Jolla,  CA

Speaker:

Jane S Hankins , MD,MS
St. Jude Children’s Research Hospital
Memphis,  TN
International Medical Graduates

back to top

Career Development Lunch



This session provides an intimate venue for trainees to meet with leaders in hematology to discuss careers in the wide array of practice areas within hematology, including basic, clinical, and translational research, PhD careers, careers in industry settings, and careers in private and clinical practice. There will are multiple tables dedicated to each career area and one faculty member at each table leading the discussion. A boxed lunch is provided. This is a first come, first served event that is usually very-well attended. The full list of topics covered are: Adult BMT; Pediatric BMT; Adult Clinical Malignant Hematology; Adult Clinical Classical Hematology; Clinical Careers in Hematology (Private Practice Careers); Government Careers (NIH and FDA); Industry Careers; Laboratory and Translational Hematology; Medical Educators in Hematology; Pediatric Clinical Hematology; PhD careers; Systems-Based Hematology; Global Hematology; Maternal Health; Medical Informatics and AI; Lifespan; and Geriatric Hematology.

Chair:

Leidy Isenalumhe
Moffitt Cancer Center
Lutz,  FL

Yvonne Adeduni Efebera , MD, MPH
Ohio Health
Columbus,  OH

Speakers:

Rakhi P P. Naik , MD
Johns Hopkins University School of Medicine
Baltimore,  MD
Hematology-Focused Fellowship Training Program (HFFTP)

Robert Stern
Dana-Farber Cancer Institute, Inc.
Boston,  MA
Hematology-Focused Fellowship Training Program (HFFTP)

Pallawi Torka
Roswell Park Comprehensive Cancer Center
Buffalo,  NY
International Graduate Hematology

Shruti Chaturvedi , MBBS
Johns Hopkins University School of Medicine
Baltimore,  MD
International Graduate Hematology

Tanya Wildes
University of Nebraska
Omaha,  NE
Geriatric Hematology

Alexander A Boucher , MD
University of Minnesota
Minneapolis,  MN
Lifespan Hematology

Matthew J. Maurer , DSc
Mayo University
Rochester,  MN
Medical Informatics & AI

Lars Bullinger
University of Ulm
Berlin,  Germany
Medical Informatics & AI

Paula James , MD, FRCPC
Queen's University
Kingston,  ON, Canada
Maternal Health

Ali Bazarbachi , MD, PhD
American University of Beirut Medical Center
Beirut,  Lebanon
International Opportunities Hematology

Kohei Hosokawa , MD, PhD
Kanazawa University Graduate School of Medical Sci
Kanazawa,  ISH, Japan
International Opportunities Hematology

Vishal Kukreti
University Health Network
Toronto,  ON, Canada
Systems Based Hematology

Shannon Elf , PhD
The University of Chicago
Chicago,  IL
PhD Careers

Parvathi Ranganathan , PHD
Ohio State University
Columbus,  OH
PhD Careers

Sara Vesely , PhD
The Univ. of OK Health Sciences Ctr.
Oklahoma City,  OK
Pediatric Clinical Hematology

Angela C Weyand , MD
University of Michigan Medical School
Ann Arbor,  MI
Pediatric Clinical Hematology

Andrew Volk , PhD
Cincinnati Children's Hospital Medical Center
Cincinnati,  OH
Laboratory and Translational Hematology

Sanjay Mohan
Vanderbilt University Medical Center
Nashville,  TN
Medical Educators in Hematology

Tapan M. Kadia , MD
MD Anderson Cancer Center
Houston,  TX
Medical Educators in Hematology

Danielle Townsley
Astra Zeneca
Potomac,  MD
Industry Careers

E. Leila Jerome Clay , MD
Johns Hopkins
Watertown,  MA
Industry Careers

Julie A. Panepinto , MD, MSPH
Division of Blood Diseases and Resources, National Heart, Lung and Blood Institute
Bethesda,  MD
Government Careers (NIH and FDA)

Cara Rabik , MD,PhD
Food and Drug Administration
Silver Spring,  MD
Government Careers (NIH and FDA)

Adrienne Hammill
Cincinnati Children's Hospital Medical Center
Cincinnati,  OH
Pediatric Hematology

Emily Saul
Columbus Oncology and Hematology
Columbus,  OH
Private Practice Hematology

Maria Carter Febres , MD
Cincinnati Children's Hospital
Cincinnati,  OH
Pediatric Hematology

Alfred I Lee , MD, PhD
Yale University School of Medicine
New Haven,  CT
Adult Classical Hematology

Payal Desai , MD
Wake Forest University
Charlotte,  NC
Adult Classical Hematology

Hanny Al-Samkari , MD
Massachusetts General Hospital, Harvard Medical School
Boston,  MA
Adult Classical Hematology

Sumithira Vasu , MD, MBBS
Ohio State University
Columbus,  OH
Adult Malignant Hematology

Basem William , MD
OhioHealth Marion General Hospital
Columbus,  OH
Adult Malignant Hematology

Sara Wall
Ohio State University Medical Center
Columbus,  OH
Adult Malignant Hematology

Nirali N. Shah , M.D.
NIH
Bethesda,  MD
Pediatric BMT/CAR-T

Rayne Rouce , MD
Texas Children's Hospital
Houston,  TX
Pediatric BMT/CAR-T

Abdullah Mohammad Khan , MBBS, MSc
The Ohio State University
Columbus,  OH
Adult BMT/Cellular Therapy

Naresh Bumma , MD
The Ohio State University Comprehensive Cancer Center
COLUMBUS,  OH
Adult BMT/Cellular Therapy

Monique A Hartley-Brown , MD
DFCI
Boston,  MA
Adult BMT/Cellular Therapy

Sajad Khazal
MD Anderson Medical Center
Loma Linda,  TX
Pediatric BMT/CAR-T

Mikkael A. Sekeres , MD
University of Miami
Miami,  FL
Adult Malignant Hematology

Oyebimpe Adesina , MD,MS
UC Davis Comprehensive Cancer Center
Sacramento,  CA
Adult Classical Hematology

Yi Zheng , PhD
Cincinnati Children's Hospital Medical Center
Cincinnati,  OH
Pediatric Hematology

Steven Fein , MD,MPH
University of Miami
Miami,  FL
Private Practice Hematology

Elaine S. Jaffe , MD
National Cancer Institute, National Institute of Health
Bethesda,  MD
Government Careers (NIH and FDA)

Maria Chaudhry
Bristol Myers Squibb
Madison,  NJ
Industry Careers

Alisa S Wolberg , PhD
University of North Carolina at Chapel Hill
Chapel Hill,  NC
Laboratory and Translational Hematology

Sandhya Panch
National Institutes of Health
Seattle,  WA
Medical Educators in Hematology

Sarah O'Brien , MD,MSc
Nationwide Children's Hospital
Columbus,  OH
Pediatric Clinical Hematology

Margaret Goodell , PhD
Center for Cell and Gene Therapy, Baylor College of Medicine
Houston,  TX
PhD Careers

Ashok Pai
University of California
Oakland,  CA
Systems Based Hematology

Ebru Koca
Baskent University
Ankara,  Turkey
International Opportunities Hematology

Lisa Baumann Kreuziger , MD,MS
Versiti
Milwaukee,  WI
Maternal Health

James S. Blachly , MD
The Ohio State University
Columbus,  OH
Medical Informatics & AI

Rebecca Kruse-Jarres , MD,MPH
University of Washington
Seattle,  WA
Lifespan Hematology

Ashley E Rosko , MD
The Ohio State University
Columbus,  OH
Geriatric Hematology

Srikanth Nagalla
Baptist Health South Florida
Miami,  FL
International Graduate Hematology

back to top